Search
for
Sort by
Research 121–150 of 130
- Cutaneous manifestations associated with substance use disorders
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Evaluation of the Relationship between Favipiravir Use Status and Telogen Effluvium in Patients Diagnosed with COVID-19
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Systemic Antifungals
- 5α-Reductases in Human Physiology: An Unfolding Story
- Subject Index
- Author Index
- ZALCITABINE
- Psoriasiform drug eruption to finasteride: Uncommon side effect of a commonly used drug
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Cutaneous Reactions to Drugs
- Dermatological Manifestations of COVID-19: A Brief Review
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Maculopapular Drug Eruption Caused by Finasteride: A Case Report
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Toxic shock syndrome: Recent developments in pathogenesis
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Cutaneous drug reactions
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Cutaneous manifestations of COVID-19